IFT52 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.663800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.997400E-01
Normal-vs-Stage2
6.231800E-01
Normal-vs-Stage3
3.519200E-01
Normal-vs-Stage4
5.652000E-01
Stage1-vs-Stage2
4.235200E-01
Stage1-vs-Stage3
4.785000E-01
Stage1-vs-Stage4
1.162000E-02
Stage2-vs-Stage3
3.003600E-01
Stage2-vs-Stage4
1.873610E-01
Stage3-vs-Stage4
7.088300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.881200E-01
Normal-vs-AfricanAmerican
7.564800E-01
Normal-vs-Asian
3.296800E-01
Caucasian-vs-AfricanAmerican
8.679200E-01
Caucasian-vs-Asian
1.664850E-01
AfricanAmerican-vs-Asian
2.684400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.235000E-01
Normal-vs-Female
6.043000E-01
Male-vs-Female
7.272200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.478600E-01
Normal-vs-Age(41-60Yrs)
8.617800E-01
Normal-vs-Age(61-80Yrs)
4.870600E-01
Normal-vs-Age(81-100Yrs)
4.408000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.456400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.998600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.621600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.160400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.805500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.799600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.204000E-01
Normal-vs-Daily Drinker
8.707000E-01
Normal-vs-Weekly Drinker
4.307000E-01
Normal-vs-Occasional Drinker
8.449600E-01
Normal-vs-Social Drinker
8.149400E-01
Non Drinker-vs-Daily Drinker
1.145950E-01
Non Drinker-vs-Weekly Drinker
7.397000E-01
Non Drinker-vs-Occasional Drinker
1.796080E-02
Non Drinker-vs-Social Drinker
1.866990E-01
Daily Drinker-vs-Weekly Drinker
3.181000E-01
Daily Drinker-vs-Occasional Drinker
4.921400E-01
Daily Drinker-vs-Social Drinker
9.018000E-01
Weekly Drinker-vs-Occasional Drinker
8.487700E-02
Weekly Drinker-vs-Social Drinker
3.965200E-01
Occasional Drinker-vs-Social Drinker
4.351400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.347000E-01
Normal-vs-Grade 2
7.151400E-01
Normal-vs-Grade 3
7.127000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.372000E-01
Grade 1-vs-Grade 3
2.420800E-01
Grade 1-vs-Grade 4
5.347000E-01
Grade 2-vs-Grade 3
9.501000E-01
Grade 2-vs-Grade 4
7.151400E-01
Grade 3-vs-Grade 4
7.127000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.472000E-01
Normal-vs-NonDiabetic
6.967400E-01
Diabetic-vs-NonDiabetic
2.531800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.317200E-01
Normal-vs-NoPancreatitis
6.483000E-01
Pancreatitis-vs-NoPancreatitis
9.609400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.514600E-01
Normal-vs-N1
6.782400E-01
N0-vs-N1
8.958800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.971800E-01
Normal-vs-TP53-NonMutant
5.259800E-01
TP53-Mutant-vs-TP53-NonMutant
7.189600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
